These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10705903)

  • 41. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression.
    Löwenberg M; Verhaar AP; van den Brink GR; Hommes DW
    Trends Mol Med; 2007 Apr; 13(4):158-63. PubMed ID: 17293163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nongenomic effects of glucocorticoids].
    Grzanka A; Jarzab J
    Pneumonol Alergol Pol; 2009; 77(4):387-93. PubMed ID: 19722144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition by insulin of glucocorticoid-induced gene transcription: involvement of the ligand-binding domain of the glucocorticoid receptor and independence from the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
    Pierreux CE; Ursø B; De Meyts P; Rousseau GG; Lemaigre FP
    Mol Endocrinol; 1998 Sep; 12(9):1343-54. PubMed ID: 9731703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
    Chen A; Vaughan J; Vale WW
    Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
    Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
    Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-transcriptional and nongenomic effects of glucocorticoids.
    Stellato C
    Proc Am Thorac Soc; 2004; 1(3):255-63. PubMed ID: 16113443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
    Cha HJ; Park MT; Chung HY; Kim ND; Sato H; Seiki M; Kim KW
    Oncogene; 1998 Feb; 16(6):771-8. PubMed ID: 9488041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular mechanisms of glucocorticoid action: what is important?
    Newton R
    Thorax; 2000 Jul; 55(7):603-13. PubMed ID: 10856322
    [No Abstract]   [Full Text] [Related]  

  • 49. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.
    Coutinho AE; Chapman KE
    Mol Cell Endocrinol; 2011 Mar; 335(1):2-13. PubMed ID: 20398732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.
    Costas M; Trapp T; Pereda MP; Sauer J; Rupprecht R; Nahmod VE; Reul JM; Holsboer F; Arzt E
    J Clin Invest; 1996 Sep; 98(6):1409-16. PubMed ID: 8823306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for glucocorticoids in the human inner ear.
    Rarey KE; Curtis LM
    Otolaryngol Head Neck Surg; 1996 Jul; 115(1):38-41. PubMed ID: 8758627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486.
    Gruol DJ; Altschmied J
    Mol Endocrinol; 1993 Jan; 7(1):104-13. PubMed ID: 8383286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of heat shock transcription factor by GR.
    Wadekar SA; Li D; Periyasamy S; Sánchez ER
    Mol Endocrinol; 2001 Aug; 15(8):1396-410. PubMed ID: 11463862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: role of the mitochondrial glucocorticoid receptor.
    Psarra AM; Sekeris CE
    Biochim Biophys Acta; 2011 Oct; 1813(10):1814-21. PubMed ID: 21664385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation.
    Messmer UK; Winkel G; Briner VA; Pfeilschifter J
    Br J Pharmacol; 1999 Aug; 127(7):1633-40. PubMed ID: 10455320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier.
    Boivin MA; Ye D; Kennedy JC; Al-Sadi R; Shepela C; Ma TY
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G590-8. PubMed ID: 17068119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Action mechanism of synthetic glucocorticoids].
    Yanase T; Nawata H
    Nihon Rinsho; 1994 Mar; 52(3):578-82. PubMed ID: 8164352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.